| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-16 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.25 | 4e-07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |